{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-326070","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2021-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.694545+00:00","generated_at":"2026-06-28T10:21:01.511315+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teva issues €2.6B and $2B sustainability-linked notes; upsizes tender offer to $4B","bullets":["€1.1B 3.750% notes due 2027 and €1.5B 4.375% notes due 2030 issued.","$1B 4.750% notes due 2027 and $1B 5.125% notes due 2029 issued.","Net proceeds used to fund tender offer for up to $4B (upsized from $3.5B) plus fees, debt repayment, and general purposes.","Interest rates may increase by up to 0.375% from May 2026 if sustainability targets not met.","Notes are senior unsecured obligations guaranteed by Teva; semi-annual interest begins May 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-326070","json":"https://secwatch.observer/filing/0001193125-21-326070.json","markdown":"https://secwatch.observer/filing/0001193125-21-326070.md","text":"https://secwatch.observer/filing/0001193125-21-326070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312521326070/0001193125-21-326070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312521326070/d249996d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T10:21:01.511315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}